United States · FDA National Drug Code directory
Gavreto
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-210_202f12fc-4f57-4e69-bf7b-73d7c1d1ed0c
- Product NDC
- 50242-210
- Form
- CAPSULE
- Composition / generic term
- Pralsetinib
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210701 / 20260930
Source-listed ingredients
- PRALSETINIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE · 50242-210-60
- 1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE · 50242-210-83
- 1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE · 50242-210-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →